Cormorant Global Healthcare Master Fund

Overview

Cormorant Global Healthcare Master Fund was established as a sector-focused investment vehicle, headquartered in Shanghai with additional offices in London and San Francisco. The firm's mandate centers on healthcare and life sciences, a vertical that demands deep regulatory, scientific, and market expertise. The fund invests across both public and private markets, targeting companies at various stages of development. Given the absence of disclosed holdings or co-investors, the full scope of deployment remains opaque. The geographic strategy spans developed markets in the US and Europe, as well as growth opportunities in Asia, particularly China. No public data exists on total assets under management, team size, or professionals. The firm has not disclosed recent operational events, fundraising rounds, or new hires. Adjacent vehicles or philanthropic structures, if any, are unknown. The key structural differentiator is the firm's pure healthcare focus combined with a global office network — a configuration that allows local intelligence gathering in three major innovation hubs. Without disclosed principals or track record, however, the firm's governance, succession, and risk management practices remain unverifiable.